BusinessWeek Company Profile: Altheus Therapeutics, Inc.
i2e Winter Magazine Cover: Altheus advances unique drug combination for IBD
Start-Up Magazine: Expecting chemical synergy to improve ulcerative colitis
Altheus receives $1.6M grant: EDGE Board OKs $6.2 million in Funding
i2e Richard Harty interview: Investors play key role in drug development
Altheus Completes Phase 1: Zoenasa Phase 1 clinical trial completed
Altheus Closes Series A Funding: Altheus Therapeutics Secures $3.6 Million